Arkema S.A. stock (FR0010313833): Analysts issue fresh rating on specialty chemicals group

Analysts have updated their view on Arkema S.A. shares, highlighting the French specialty chemicals group’s positioning in adhesives, advanced materials and coatings.

Analysts have issued a fresh rating on Arkema S.A. stock, underscoring the French specialty chemicals group’s role in adhesives, advanced materials and coatings solutions for global industrial markets. The company trades over the counter in the United States under the symbol ARKAY and is listed in Paris under the ticker AKE, according to Investing.com data as of May 9, 2026.

As of: 11.05.2026

By the editorial team – specialized in equity coverage.

At a glance

• Name: Arkema S.A.
• Sector/industry: Basic Materials / Specialty Chemicals
• Headquarters/country: Colombes, France
• Core markets: Europe, United States, Asia
• Key revenue drivers: Adhesive solutions, advanced materials, coatings solutions, intermediates
• Home exchange/listing venue: Euronext Paris (ticker AKE); OTC in the US (ARKAY)
• Trading currency: EUR (Paris), USD (OTC)

Arkema S.A.: core business model

Arkema S.A. operates as a global specialty chemicals and advanced materials company, originally spun off from Total’s chemicals activities in the mid?2000s. The group focuses on higher?value specialty products rather than commodity chemicals, targeting industrial customers in construction, automotive, electronics, energy and consumer goods.

Its portfolio is organized into four main segments: adhesive solutions, advanced materials, coatings solutions and intermediates, with the first three representing the more specialized, higher?margin businesses. Geographically, Arkema’s sales are split roughly evenly among Europe, the United States and Asia, giving US investors exposure to both mature and emerging?market demand cycles.

Main revenue and product drivers for Arkema S.A.

Adhesive solutions form a key revenue pillar, supplying industrial adhesives and sealants used in construction, transportation and packaging. Advanced materials include high?performance polymers, resins and specialty fluids that serve sectors such as aerospace, electronics and medical devices.

Coatings solutions provide binders and additives for paints and protective coatings, while the intermediates segment covers more commodity?like chemical products that support the broader portfolio. According to sector analysis, Arkema’s products range from epoxidized soybean oil?based plasticizers, bio?stabilizers and PVC additives applied in packaging, cables and PVC medical applications, reinforcing its position in performance and sustainable materials.

Why Arkema S.A. matters for US investors

For US investors, Arkema S.A. offers a way to gain exposure to structural trends in green building, data centers and advanced manufacturing through its specialty chemicals and advanced materials. The company’s roughly one?third of sales in the United States links its performance to North American industrial activity, infrastructure spending and technology investment.

Recent analyst commentary reflects ongoing interest in Arkema’s transition toward higher?value materials and its ability to navigate raw?material and demand cycles. At the same time, the stock carries the typical risks of a global chemical producer, including energy costs, regulatory changes and competitive pressures, which are particularly relevant for US?listed ADRs and OTC shares.

Conclusion

Arkema S.A. continues to position itself as a diversified specialty chemicals player with significant exposure to the United States and other major industrial markets. Recent analyst commentary reflects ongoing interest in the company’s transition toward higher?value materials and its ability to navigate raw?material and demand cycles.

For US investors, the stock offers a way to gain exposure to structural trends in green building, data centers and advanced manufacturing, while also carrying the typical risks of a global chemical producer, including energy costs, regulatory changes and competitive pressures. The combination of a Paris listing and an OTC presence in the United States provides multiple access points, but also requires attention to currency and liquidity differences.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.